Skip to main content
. Author manuscript; available in PMC: 2024 Jan 1.
Published in final edited form as: Pediatr Blood Cancer. 2022 Aug 8;70(1):e29921. doi: 10.1002/pbc.29921

Table 2.

Demographic and clinical characteristics of patients by subgroup achieving CR or VGPR/PR prior to ASCT.

CR vs PR/VGPR pts CR PR/VGPR
Subtotal n=8 n=16
Gender (F:M) 3:5 8:8
Age (in years)
at diagnosis 1.4 (0.1–2.6) 2.1 (0.3–7.3)
at ASCT 3.2 (2.3–9.5) 3.8 (2.8–9.7)
RB germline status
Positive
Negative
Unknown
2
2
4
3
11
2
Time btw dx and relapse (in months) 7.4 (4.0–92.4) 11.8 (3.1–83.9)
RT post ASCT (outcome)
Yes
No
3 (all RBFS)
5 (3 RBFS)
9 (8 RBFS)
7 (6 RBFS)
Overall survival at 5 years (P = 0.4531) 68.5% 86.5%